48/120
2.0 / 5 stars
All 120 Win/Lose results shown below
HAE Roast Me summary
HAEMONETICS CORP (HAE). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinHAE / S&P 33.07% / 15.20% |
LoseHAE / S&P 0.44% / 15.00% |
LoseHAE / S&P -36.70% / 50.40% |
| 2026-Q10/3 |
LoseHAE / S&P -29.68% / -4.33% |
LoseHAE / S&P -1.97% / 11.30% |
LoseHAE / S&P -38.07% / 27.70% |
| 2025-Q42/3 |
WinHAE / S&P 64.44% / 2.65% |
LoseHAE / S&P -4.02% / 9.00% |
WinHAE / S&P 42.91% / 13.40% |
| 2025-Q31/3 |
LoseHAE / S&P -34.67% / 8.12% |
LoseHAE / S&P -2.45% / 4.61% |
WinHAE / S&P 41.91% / 13.45% |
| 2025-Q22/3 |
WinHAE / S&P 17.40% / 10.94% |
LoseHAE / S&P 0.91% / 4.83% |
WinHAE / S&P 46.64% / 10.63% |
| 2025-Q11/3 |
LoseHAE / S&P -18.61% / -4.27% |
LoseHAE / S&P 3.95% / 4.98% |
WinHAE / S&P 44.54% / 10.57% |
| 2024-Q41/3 |
LoseHAE / S&P -2.86% / 2.41% |
WinHAE / S&P 8.14% / 5.25% |
LoseHAE / S&P 3.25% / 6.15% |
| 2024-Q31/3 |
LoseHAE / S&P -2.84% / 5.89% |
WinHAE / S&P 9.84% / 5.89% |
LoseHAE / S&P -3.21% / 6.11% |
| 2024-Q21/3 |
LoseHAE / S&P -3.07% / 4.28% |
WinHAE / S&P 9.47% / 5.38% |
LoseHAE / S&P -15.85% / 5.12% |
| 2024-Q11/3 |
LoseHAE / S&P -0.19% / 10.56% |
WinHAE / S&P 12.01% / 5.71% |
LoseHAE / S&P 2.23% / 5.59% |
| 2023-Q42/3 |
LoseHAE / S&P -4.54% / 11.69% |
WinHAE / S&P 12.48% / 6.81% |
WinHAE / S&P 32.97% / 7.78% |
| 2023-Q33/3 |
WinHAE / S&P 5.21% / -3.27% |
WinHAE / S&P 14.35% / 7.52% |
WinHAE / S&P 50.00% / -5.03% |
| 2023-Q22/3 |
LoseHAE / S&P 2.89% / 8.74% |
WinHAE / S&P 18.75% / 9.50% |
WinHAE / S&P 102.29% / -8.57% |
| 2023-Q12/3 |
LoseHAE / S&P 5.21% / 7.50% |
WinHAE / S&P 17.67% / 10.77% |
WinHAE / S&P 166.67% / -15.69% |
| 2022-Q41/3 |
LoseHAE / S&P 6.24% / 7.56% |
LoseHAE / S&P HAE unavailable / 11.88% |
WinHAE / S&P 330.23% / -17.99% |
| 2022-Q32/3 |
WinHAE / S&P 13.58% / -4.88% |
LoseHAE / S&P HAE unavailable / 13.47% |
WinHAE / S&P 176.67% / -1.41% |
| 2022-Q21/3 |
WinHAE / S&P 3.10% / -16.10% |
LoseHAE / S&P HAE unavailable / 13.71% |
LoseHAE / S&P 4.80% / 11.04% |
| 2022-Q11/3 |
WinHAE / S&P 19.19% / -4.60% |
LoseHAE / S&P 14.10% / 15.97% |
LoseHAE / S&P -45.81% / 42.23% |
| 2021-Q40/3 |
LoseHAE / S&P -24.86% / 11.03% |
LoseHAE / S&P HAE unavailable / 15.00% |
LoseHAE / S&P -79.72% / 96.40% |
| 2021-Q31/3 |
WinHAE / S&P 5.93% / 0.58% |
LoseHAE / S&P HAE unavailable / 10.77% |
LoseHAE / S&P -71.15% / 69.42% |
| 2021-Q20/3 |
LoseHAE / S&P -39.97% / 8.55% |
LoseHAE / S&P HAE unavailable / 6.58% |
LoseHAE / S&P -32.80% / 51.81% |
| 2021-Q10/3 |
LoseHAE / S&P -6.52% / 6.17% |
LoseHAE / S&P -11.94% / -1.06% |
LoseHAE / S&P 4.73% / 7.39% |
| 2020-Q42/3 |
WinHAE / S&P 36.10% / 12.15% |
LoseHAE / S&P HAE unavailable / -3.72% |
WinHAE / S&P 38.56% / -33.42% |
| 2020-Q31/3 |
LoseHAE / S&P -2.58% / 8.93% |
LoseHAE / S&P HAE unavailable / -2.04% |
WinHAE / S&P 60.00% / -27.10% |
| 2020-Q21/3 |
LoseHAE / S&P -10.13% / 20.54% |
LoseHAE / S&P HAE unavailable / -0.46% |
WinHAE / S&P 100.00% / -27.11% |
| 2020-Q12/3 |
WinHAE / S&P -13.26% / -19.60% |
LoseHAE / S&P 2.16% / 3.47% |
WinHAE / S&P 42.31% / -14.75% |
| 2019-Q41/3 |
LoseHAE / S&P -8.91% / 9.07% |
LoseHAE / S&P HAE unavailable / 5.36% |
WinHAE / S&P 75.86% / 2.99% |
| 2019-Q32/3 |
WinHAE / S&P 4.82% / 1.70% |
LoseHAE / S&P HAE unavailable / 5.02% |
WinHAE / S&P 225.00% / 0.21% |
| 2019-Q22/3 |
WinHAE / S&P 37.56% / 4.30% |
LoseHAE / S&P HAE unavailable / 6.64% |
WinHAE / S&P 116.28% / 8.65% |
| 2019-Q11/3 |
LoseHAE / S&P -12.56% / 13.65% |
LoseHAE / S&P 7.04% / 8.12% |
WinHAE / S&P 22.35% / 14.29% |
| 2018-Q41/3 |
WinHAE / S&P -12.68% / -13.52% |
LoseHAE / S&P HAE unavailable / 9.05% |
LoseHAE / S&P HAE unavailable / 18.23% |
| 2018-Q32/3 |
WinHAE / S&P 27.77% / 7.71% |
LoseHAE / S&P HAE unavailable / 10.21% |
WinHAE / S&P 471.43% / 19.06% |
| 2018-Q22/3 |
WinHAE / S&P 22.58% / 3.43% |
LoseHAE / S&P HAE unavailable / 9.03% |
WinHAE / S&P 514.29% / 14.46% |
| 2018-Q11/3 |
WinHAE / S&P 25.96% / -0.76% |
LoseHAE / S&P 2.01% / 7.68% |
LoseHAE / S&P HAE unavailable / 12.46% |
| 2017-Q41/3 |
WinHAE / S&P 29.44% / 6.64% |
LoseHAE / S&P HAE unavailable / 7.03% |
LoseHAE / S&P -212.90% / 13.82% |
| 2017-Q31/3 |
WinHAE / S&P 13.62% / 4.48% |
LoseHAE / S&P HAE unavailable / 5.68% |
LoseHAE / S&P HAE unavailable / 17.57% |
| 2017-Q20/3 |
LoseHAE / S&P -2.66% / 3.09% |
LoseHAE / S&P HAE unavailable / 4.83% |
LoseHAE / S&P HAE unavailable / 17.74% |
| 2017-Q10/3 |
LoseHAE / S&P 0.92% / 6.07% |
LoseHAE / S&P HAE unavailable / 3.67% |
LoseHAE / S&P HAE unavailable / 13.32% |
| 2016-Q41/3 |
WinHAE / S&P 11.02% / 3.82% |
LoseHAE / S&P HAE unavailable / 2.09% |
LoseHAE / S&P HAE unavailable / 7.05% |
| 2016-Q31/3 |
WinHAE / S&P 24.91% / 3.85% |
LoseHAE / S&P HAE unavailable / 0.20% |
LoseHAE / S&P -336.73% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | HAE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 90.42% | 20.78% |
| Annualized return | 90.42% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | HAE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 62.73% | 83.14% |
| Annualized return | 10.23% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | HAE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 178.28% | 319.30% |
| Annualized return | 10.78% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |